Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Glaukos: Q4 Earnings Snapshot AP - Tue Feb 17, 3:44PM CST

Glaukos: Q4 Earnings Snapshot

GKOS : 120.27 (+2.71%)
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results Business Wire - Tue Feb 17, 3:05PM CST

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 120.27 (+2.71%)
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR Business Wire - Wed Jan 28, 6:00AM CST

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 120.27 (+2.71%)
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17 Business Wire - Tue Jan 20, 6:00AM CST

Conference Call and Webcast Scheduled for 1:30 p.m. PT

GKOS : 120.27 (+2.71%)
NASDAQ sign at times square at night by Lucky-photographer via iStock
Stock Indexes Settle Lower on Tech Weakness Barchart - Wed Jan 14, 3:39PM CST

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.07%. March...

MSTR : 131.05 (+1.24%)
GOOGL : 314.98 (+4.01%)
MPC : 196.76 (+0.15%)
GLXY : 21.20 (-1.99%)
RIVN : 15.27 (-2.05%)
ABNB : 127.89 (+1.65%)
COIN : 171.35 (+3.26%)
TGTX : 29.53 (+0.24%)
OXY : 51.84 (+0.60%)
TSLA : 411.82 (+0.03%)
^BTCUSD : 67,453.07 (-0.55%)
SPY : 689.43 (+0.72%)
Candlestick chart selloff by Don Huan via Shutterstock
Stocks Retreat as Big Tech Falters Barchart - Wed Jan 14, 10:26AM CST

The S&P 500 Index ($SPX ) (SPY ) today is down -0.96%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.53%. March E-mini S&P futures...

MSTR : 131.05 (+1.24%)
GOOGL : 314.98 (+4.01%)
MPC : 196.76 (+0.15%)
GLXY : 21.20 (-1.99%)
RIVN : 15.27 (-2.05%)
COIN : 171.35 (+3.26%)
TGTX : 29.53 (+0.24%)
OXY : 51.84 (+0.60%)
TSLA : 411.82 (+0.03%)
^BTCUSD : 67,453.07 (-0.55%)
SPY : 689.43 (+0.72%)
META : 655.66 (+1.69%)
Stock crash red market down by Bigc Studio via Shutterstock
Stocks Pressured by Tech Weakness and Iran Tensions Barchart - Wed Jan 14, 9:17AM CST

The S&P 500 Index ($SPX ) (SPY ) today is down -0.75%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.22%. March E-mini S&P futures...

AMAT : 375.38 (+1.50%)
GOOGL : 314.98 (+4.01%)
MPC : 196.76 (+0.15%)
AVGO : 332.65 (-0.40%)
CVX : 183.93 (-0.46%)
FN : 546.13 (+6.29%)
RIVN : 15.27 (-2.05%)
$IUXX : 25,012.62 (+0.87%)
ZNH26 : 112-300s (-0.03%)
MSFT : 397.23 (-0.31%)
TGTX : 29.53 (+0.24%)
OXY : 51.84 (+0.60%)
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance Business Wire - Tue Jan 13, 3:05PM CST

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 120.27 (+2.71%)
Glaukos Announces Participation in J.P. Morgan Healthcare Conference Business Wire - Tue Dec 16, 2025

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 120.27 (+2.71%)
Glaukos Announces Participation in Upcoming Investor Conferences Business Wire - Mon Nov 3, 2025

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 120.27 (+2.71%)

Barchart Exclusives

If Palantir is Near a Bottom, What's the Best Play in PLTR Stock? Barchart - 46 minutes ago
Palantir put options have high premiums for out-of-the-money exercise prices, making them attractive to short-sellers. For example, selling short a 7% lower exercise put yields 3.7% over one month and 2.7% with a 11% lower put strike price. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot